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Immunologic tolerance was originally defined as  specific hyporesponsiveness to  an 
antigen which results from prior contact with that antigen (1, 2). The concept of natural 
tolerance to self-antigens was perceived by Burnet (3) as the deletion of clones reactive to 
autologous  antigens  after  contact  of these  antigens  with  the  reactive  cells'  specific 
antigen receptors during the development of the cell's immunologic competence. If  such a 
theory were to have physiological relevance, then several predictions should be realized: 
(a) developing cells should be significantly more susceptible to tolerance induction than 
their mature counterparts; (b) tolerance should be inducible over a wide range of antigen 
concentrations,  since the concentrations of different self-antigens present presumably 
vary; (c) since the spectrum of self-antigens is diverse, the development of unresponsive- 
ness should  be plausible with  a  wide  variety of antigenic  structures;  (d)  since  bone 
marrow-derived precursors to antibody-forming cells (B cells) presumably mature inde- 
pendently of other cell types, induction of B-cell tolerance should occur in the absence of 
antigen-specific thymus-derived lymphocytes (T cells); (e)  the discrimination between 
self and nonself would  be absolute,  and therefore,  tolerance should  exhibit exquisite 
determinant specificity. 
Several  models  have  been  developed  to  examine  B-cell  tolerance;  however,  these 
approaches have  generally  been  restricted  to  the  analysis  of adult  responses,  since 
responses by neonatal cells and the necessary controlled comparisons of neonatal and 
adult cells have been technically difficult to achieve (4). Furthermore, the requirement 
for T cells in the elicitation of maximal B-cell stimulation has engendered considerable 
uncertainty over the cellular level of any unresponsiveness induced (4-6). The demon- 
strated role of suppressor cells or soluble factors in the development of unresponsiveness 
has added to the difficulties in determining whether tolerance occurs at the B- or T-cell 
level (7-10).  Finally, antigen-induced redistribution of cells from their normal migratory 
pathways or temporary antigen "blockade" of cell receptors may be misconstrued as a 
state of tolerance (11). 
T-cell tolerance, suppressor T cells, and receptor blockade may represent valid biologi- 
cal mechanisms and may reflect important regulatory controls on B-cell responsiveness. 
However, the existence of such mechanisms does little to elucidate the possible role of a 
"clonal abortion" mechanism in B-cell responses  (11). Furthermore,  systems in which 
putative B-cell tolerance has been achieved usually involve the exposure of B cells to high 
concentrations  of antigens,  at least for induction  (4),  and have been limited to such 
antigens as serum proteins, particularly immunoglobulins (4-6), haptenated homologous 
serum proteins, erythrocytes or undegradable synthetic copolymers (12-18),  and a few "T- 
independent" antigens (19, 20). Lastly, in these models, B-cell tolerance is often reversi- 
ble with factors derived from T cells or mitogens and has not been highly specific (6, 16, 
21, 22). 
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Recent comparative studies of neonatal and adult B cells have demonstrated differ- 
ences  in  susceptibility  to  anti-immunoglobulin  or  anti-idiotype  antibody-induced 
suppression (23-26),  implying that neonatal (i.e., immature or developing) cells may be 
highly susceptible to tolerance  induction.  In addition,  Nossal  and Pike have demon- 
strated that developing B cells in the adult bone marrow may indeed be susceptible to 
tolerance induction (27). Therefore, a model of B-cell tolerance which compares neonatal 
(immature) and adult (mature) B-cell responses should permit a physiologically relevant 
approach to the study of self-recognition mechanisms. 
Previous  studies  from  this  laboratory  have  demonstrated  that  the  splenic 
focus technique permits detectable stimulation of individual  neonatal  or adult 
clonal precursor cells  (28-32).  Since  tolerogens  can be added to fragment cul- 
tures and removed before stimulation,  this system provides a  unique  opportu- 
nity to compare the interaction of tolerogen with individual neonatal and adult 
cells. The results demonstrate that in this model of B-cell tolerance: (a) splenic 
B cells are susceptible to tolerance induction only during the first few days after 
birth;  (b)  tolerance  of developing  B  cells  can  be  established  by  hapten  at 
concentrations  ranging  from  10  -5  M  to  10  -9  M  on  a  wide  variety of carriers, 
including those generally assumed to be immunogenic; (c) the tolerance induced 
is  highly  specific,  discriminating  even between the  dinitrophenylated  (DNP) 1 
and trinitrophenylated  (TNP) determinants;  and (d) this tolerance induction is 
T-cell independent,  time dependent,  and cannot be reversed by removal of the 
tolerogen.  These  findings  suggest  intrinsic  differences between  neonatal  and 
adult B cells and may provide a model for the study of tolerance to self-antigens. 
Materials and Methods 
Hapten-Carrier Conjugates.  The preparation ofLirnulus polyphernus hemocyanin  (Hy), dini- 
trophenylated hemocyanin (DNP-Hy, i0  mol of  DNP per 100,000  g of  Hy), and trinitrophenylated 
hemocyanin (TNP-Hy, 10  tool  of  TNP per 100,000  g of  Hy) have been  previously  described  (29,  31). 
Human gamma globulin (H-/G,  Cohn fraction  If, Nutritional  Biochemicals Corporation, Cleve- 
land, Ohio) was purified  by the method of  Chiller  et al. (33).  Mouse gamma globulin  (M~,G)  was 
prepared from ascites  fluid  of mice carrying the plasmacytoma 31 C  (K, ~/i)  by the procedure 
described  by Rowe and Fahey (34).  Chicken albumin (OVA, Fraction  V, Pentex, Inc.,  Kankakee, 
Ill.)  was used without further  purification.  The following DNP conjugates were prepared and 
assessed  for  DNP content  as  previously  described  (29,  35):  DNP-HTG (10  tool  of  DNP per 150,000  g 
of  H~G), DNP-M~/G (15-20  tool  of  DNP per 150,000  g of  M~/G),  and DNP-OVA  (4  tool  of  DNP per 
44,000 g of OVA). The random copolymer of D-glutamic acid and D-lysine (o-GL, Miles-Yeda, Ltd., 
Rehovot, Israel) had a ratio of G:L of 3:2.05 and was conjugated to trinitrobenzene sulfonic acid 
(Nutritional  Biochemicals  Corporation)  by a  modification  of the procedure  of Rittenberg and 
Amkraut (36). 50 mg of 2,4,6-trinitrobenzene  sulfonate was added to 150 mg D-GL  dissolved in 10 
ml of 0.28 M cacodylic acid, pH 7.2, stirred overnight at room temperature, and dialyzed exten- 
sively against distilled  water at 4°C for 48 h: (TNP-D-GL, 20 mol of TNP per 40,600 g of I)-GL). 5- 
dimethylarninonaphthalene-l-sulfonyl-N-acetyl-B-alanylglycylglycine  Boc  hydrazide-hemocya- 
nin (DANS-AGG-Hy), a dansyl-tripeptide spacer-Hy conjugate, a gift from Mr. Nolan Sigal, was 
prepared by the method of Inman et al. (37), and contained 10 mol of hapten per tool ofHy. DNP,- 
S-papain was the generous gift of.Dr.  S. J. Singer (38). Aggregates were removed by passage 
through a Sephadex  G-50 column. 
Abbreviations used in thispaper: CFA, complete Freund's adjuvant; D-GL, D-glutamic acid and 
D-lysine; DANS-AGG-HY,  5-dimethylaminonaphthalene-l-sulfonyl-N-acetyl-B-alanylglycylgly- 
cine  Boc Hydrazide-hemocyanin;  DMEM,  Dulbecco's  modified  Eagle's  medium; DNP-Hy, dinitro- 
phenylated-hemocyanin;  HTG, human gamma globulin;  Hy, hemocyanin;  M~G, mouse gamma 
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Animals.  6-8-wk-old BALB/cJ mice  were  obtained  from  The  Jackson  Laboratory, Bar  Harbor, 
Maine or Carworth Division, Becton Dickinson &  Co.,  Rutherford, N. J. BALB/cAnN  were 
acquired through  the  Institute  for  Cancer  Research, Philadelphia,  Pa. Mice  from  all  three  sources 
were used interchangeably in  these studies.  Neonatal mice were obtained from breeding  pairs  of 
BALB/cAnN  mice in our own mouse colony as well as from pregnant BALB/cAnN  females 
obtained from the Institute  for  Cancer Research, Philadelphia,  Pa. 
Immunizations.  6-8-wk-old  mice received an  intraperitoneal  injection of 0.1  mg of Hy  in 
complete Freunds' adjuvant (CFA) 6-12 wk before use as irradiated, carrier-primed recipients for 
adoptive adult or neonatal cell transfer. 
Preparation of Cell Suspensions.  Suspensions of neonatal or adult BALB/c spleen cells were 
prepared by either extensively flushing the spleens with RPMI 1640 plus 25 mM HEPES and 10% 
fetal calf serum (FCS) or by gently pressing small sections of spleen between two glass slides into 
media.  Large  cell clumps were removed by filtration through  a  nylon screen,  and viability of 
nucleated cells was determined by the trypan blue exclusion method. 
Cell Transfers and In Vitro Tolerance Induction.  A modification of the in vitro splenic focus 
technique (29-32)  was developed for the study of tolerance induction of neonatal and adult spleen 
cells. 4  ×  10  e spleen cells from unimmunized neonatal or adult mice were injected intravenously 
into Hy carrier-primed recipients which had been irradiated at 1,300 R, 4-6 h earlier. 16-18 h after 
transfer, the recipient spleens were removed and sliced into l-ram fragments by a McIlwain Tissue 
Chopper (Brinkmann Instruments,  Inc., Westbury, N. Y.). Fragments were transferred individ- 
ually into wells of microtiter plates (Linbro Chemical Co., New Haven, Conn.) and cultured for 
various time intervals in either Dulbecco's modified Eagle's medium  (DMEM) or with various 
hapten-carrier  conjugates  diluted  in  DMEM.  The fragments  were  subsequently  washed  thor- 
oughly with DMEM and then stimulated with either DNP-Hy, TNP-Hy,  or DANS-AGG-Hy at 
hapten concentrations of 1 ×  10  -6 or 5  ×  10  -7 M. Culture fluids were changed every 3 days. 
Radioirnmunoassay.  20  ~l of culture  fluids collected 10 or  13  days  after  stimulation  were 
quantitatively  assayed  for  antihapten  antibody.  The  radioimmunoassays  were  performed  by 
detecting  immunoglobulin  bound  to  2,4-dinitrophenyl-lysine-bromoacetylcellulose  immunoad- 
sorbent  (DNP-LYS-BAC),  2,4,6-trinitrophenyl-lysine-BAC  (TNP-LYS-BAC),  or  dansyl-lysine- 
BAC  (DANS-LYS-BAC) prepared  by  general  procedures  described  previously  (29-31).  Bound 
immunoglobulins were quantified with  ~25I-labeled purified rabbit  antimouse Fab or goat anti- 
mouse IgM (p) or IgG1 (T1) antibody (39, 40). 
Depletion ofT Lymphocytes.  Donor spleen cell suspensions were treated with AKR anti-~ C3H 
serum (a gift from Dr. C. A. Janeway, Jr.) and guinea pig complement as previously described 
(41). These conditions have previously been shown to be capable of completely abrogating "helper" 
activity of donor T-lymphocyte populations and lack cytotoxicity for B cells (41). 
Results 
Parameters of Tolerance  Induction  in Neonatal Splenic B  Cells.  The effi- 
ciency of tolerance induction by preincubation of fragment cultures with 10  -6 M 
DNP-M~G is summarized in Table I. It is clear that adult splenic B cells were 
not tolerized, whereas both IgM and IgG1 responses in day 3 splenic B cells were 
markedly reduced. Furthermore, the neonatal B cells capable of yielding clones 
producing only IgM antibodies appeared most susceptible to tolerance induction. 
The specificity of tolerance induction in neonatal B  cells was examined,  and 
the results indicate  that preincubation with M~G alone did not influence the 
number of hapten-specific clonal precursor cells specific for DNP (94% of control 
response).  Most significant,  however,  is the fact that the tolerance induced in 
neonatal B cells by DNP-MyG caused no measurable diminution in the response 
of DANS-reactive cells or even of cells reactive to the closely related hapten TNP 
as demonstrated in Table H. 
Age Dependence of Tolerance Susceptibility.  Fig. 1 summarizes the normal- 
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TABLE  I 
The Effect of Incubation with DNP-MTG on the Frequency and Isotype of Monoclonal Anti- 
DNP Antibody Responses 
Heavy chain class 
IgM  IgG~  IgM + IgG~ 
Age of do-  Tolerogen  Number 
nor spleen  (I0  -e  M  clones  per I06  Number  Number  Number 
DNP-  spleen cells  clones  clones 
cells  MTG)  transferred*  per 10  e  Total  per 106  Total  clones  per  Total 
106  cells 
cells  clones  cells  clones  clones  trans- 
trans-  trans-  ferred 
ferred  ferred 
%  %  % 
Adult  (8-10  -  1.92 _+ 0.21  0.28  16.2  1.29  74.5  0.16  9.3 
wk)  +  1.77 _+ 0.19  0.39  27.1  0.95  65.7  0.10  7.0 
Neonatal  (3  -  1.34 ±  0.13  0.47  40.5  0.65  55.7  0.03  2.9 
days)  +  0.36 ±  0.03  0.02  6.8  0.32  93.1  0.0  0.0 
* 4  x  106 donor spleen cells were transferred to each recipient mouse. Recipient fragment culturee were incubated in the 
presence or absence of 10  -e M DNP-M~,G for 24 h, washed, and stimulated with DNP-Hy at 10  -e M DNP. Clones were 
detected by radioimmunoassay of culture fluids with l~I-labeled antimouse Fab, IgM, or IgG~. 
TABLE  IT 
Specificity of Tolerance Induced in Neonatal  and Adult Spleen Fragment Cultures 
Total num- 
ber of  donor  Number of  Percent of 
Tolerogen (10  -6  Stimulating antigen  clones  per 106  control  re-  Age of  donor  cells  ana-  M) 
spleen cells  lyzed  cells  transferred  sponse 
x I0  -e  * 
Adult (8-10 
wk) 
Neonatal (3 
days) 
124  --  DNP-Hy  1.92 -+ 0.21 
128  DNP-MTG  DNP-Hy  1.77 -+ 0.19  92.1 
40  -  TNP-Hy  1.63 -+ 0.31 
24  DNP-MTG  TNP-Hy  1.82 -+ 0.48  111.6 
16  --  DANS-AGG-Hy  0.56 ± 0.06 
16  DNP-MTG  DANS-AGG-Hy  0.56 ± 0.06  100.0 
86.4  -  DNP-Hy  1.34 -+ 0.13 
86.4  DNP-MTG  DNP-Hy  0.36 -+ 0.03  26.8 
30.4  -  TNP-Hy  1.08 ±  0.11 
30.4  DNP-MTG  TNP-Hy  1.08 ±  0.13  100.0 
16.0  -  DANS-AGG-Hy  0.52 ±  0.25 
16.0  DNP-MTG  DANS-AGG-Hy  0.62 ±  0.37  119.2 
* 4-8 x  106 donor spleen cells  were transferred to each recipient  mouse. Recipient fragment cultures were 
incubated in  the  presence or  absence of  10  "~  M  DNp-MTG  for  24 h, washed, and stimulated with either  DNP- 
Hy at 10  -e  M  DNP, TNP-Hy at 10  -e  M TNP, or  DANS-AGC~Hy  at  5 × 10  -7  M DANS. Clones  were detected  by 
radioimmunoassay of  culture  fluids  with 1~I-labeled  antimouse Fab, IgM, or IgG~. 
containing donor cells  derived from mice of  varying ages. All of  the cell  popula- 
tions responded in the absence of  putative tolerogen treatment. Furthermore, 
the response of  adult spleen cells  was unaffected by in vitro  culture with DNP- 
MTG. In contrast, the response of  fetal  liver  cells  at 18 days of  gestation was 
entirely  abrogated after  tolerogen treatment, and greater than 90% of  the DNP- 
specific  clones from day 1 spleen cells  were susceptible to tolerance induction. 
However, the frequency of  cells  not susceptible  continues to increase thereai~er 
and reaches adult levels  of  resistance to  tolerance induction by  day 7  after  birth. 
These results  suggest that the susceptibility  to tolerance induction is  restricted 
to B cells  early in their development. 
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F*o. 1.  The dependence of in vitro  tolerance induction on the age of  the B-cell  donor. 
Fragment cultures  containing spleen  or  liver  cells  of  donors  of  various ages  were  exposed  to 
DNP-M~/G for 24 h before  stimulation with DNP-Hy (g-Q). Each point represents data 
obtained from a minimum of  8 x 10  ~  donor cells  _+ standard error.  (/x)  represents similar 
experiments  with  donor  cells  treated  with anti-8  antiserum and C' before  transfer.  100% of 
the control  response represents the total  response of DNP-specific cells  cultured in the 
absence of  tolerogen. 
tolerance induction, day 3 neonatal and adult spleen cells were pretreated with 
anti-0  antiserum  and  C'  before cell transfer.  The  results  of this  analysis  are 
presented as the additional points at day 3 and 8 wk in Fig. 1 and indicate that 
the same degree of unresponsiveness was observed in treated and untreated day 
3 neonatal cells in fragment cultures. 
Time Dependence of Tolerance Induction.  To establish the requirements for 
optimal unresponsiveness in this system, day 3 neonatal or adult spleen frag- 
ments were exposed to DMEM or 10  -6 M DNP-MTG for various time intervals, 
washed, and stimulated with 10  -6 M DNP-Hy. The normalized results  (Fig.  2) 
show that whereas 24-h exposure to DNP-MTG had no effect on adult splenic B 
cells,  a  significant  reduction in neonatal  B-cell responsiveness was seen after 
only 6 h  of culture in the presence of DNP-MTG, and maximal  reduction was 
achieved after  12-24 h  of culture.  However, it is apparent that a  critical time 
period is required for the neonatal cells to be rendered unresponsive.  In addi- 
tion,  tolerance induction  apparently  involves more complex interactions  than 
simple binding of telerogen, since exposure to tolerogen for 2 h  did not render 
most neonatal cells unresponsive. 
Antigen  Concentration  and  Carrier  Independence  of  Tolerance  Induc- 
tion.  Previous studies have provided evidence that B-cell tolerance induction is 
dependent on high antigen concentrations (4, 5, 43) and limited to a few carriers 
(12-20).  From the results  presented in Table HI it is evident that  DNP-MTG 
failed to induce tolerance in adult splenic B cells at any concentration up to 10  -5 
M  haptenic determinant.  This is in marked contrast to the response of day 3 
splenic B cells in which significant reduction in the number of responsive cells 
was evident at concentrations as low as 10  -9 M DNP-MTG. 
If the unresponsiveness observed in fragment cultures of neonatal splenic B 
cells after preincubation with DNP-MTG represents a generalized characteristic 1332  TOLERANCE  INDUCTION  OF  NEONATAL  MURINE  B  CELLS 
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FIG.  2.  The  induction of in  vitro  tolerance as  a  function of time.  Fragment cultures 
containing day 3 neonatal (O -  0) or adult ( x -  x) spleen cells were exposed to 10 -e M DNP- 
MTG for various time intervals before stimulation with DNP-Hy. Each point represents 
data obtained from a minimum of 8 x  106 donor cells -+ standard error. 100% of the control 
response represents the total  response of DNP-specific cells cultured in the absence of 
tolerogen. 
of neonatal  (immature) cell populations  and not a  property of a  particular 
tolerogen, then presumably the majority of these cells should also be rendered 
unresponsive after culture with other hapten-protein conjugates. Table HI also 
presents results demonstrating that while adult splenic B cells remain unaf- 
fected by any of the hapten-carrier conjugates, day 3 neonatal splenic B cells 
were tolerized by a wide variety of hapten-carrier conjugates. In addition, the 
results suggest an apparent requirement for multivalent presentation of the 
relevant hapten for the induction of tolerance, since neither DNP-lysine nor 
DNP1-S-papain (which is mainly in the monomer form) are effective tolerogens. 
It should be noted that in all of these studies the quantity of antibody produced 
by responding fragments after tolerogen treatment was the same as untreated 
fragments.  Thus,  treatment of mature  spleen  cells  with  conjugates highly 
tolerogenic in other systems (14, 16, 18) appears irrelevant to either the number 
of responding cells or total antibody production under conditions described here. 
This is presumably the result of either efficient removal of tolerogen or ex- 
tremely efficient stimulation in an environment primed to the relevant carrier. 
Discussion 
These studies were undertaken to determine whether B lymphocytes, during 
their development, mature through a stage in which they are extremely suscep- 
tible to tolerance induction. To examine this proposition, the response of splenic 
B cells from neonatal mice was analyzed. Neonatal spleens are presumably 
enriched in  immature,  developing cells and  have  been demonstrated to  be 
highly susceptible to suppression by anti-immunoglobulin (23-25) or anti-idi- 
otypic antibodies (26). The results in the present study indicate that B cells, 
early in their development, are readily tolerized in vitro in a  highly specific 
manner, by low concentrations of hapten on a wide array of carriers, while the ELEANOR  S.  METCALF  AND  NORMAN  R.  KLINMAN  1333 
TABLe. HI 
The Induction of Tolerance in Fragment Cultures of  Neonatal and Adult Spleen Cells by 
Various Hapten and Hapten-Protein  Conjugates 
Total num- 
Age of donor  ber of cells  Stimulat-  Percent of con- 
spleen cells  analyzed x  Tolerogen$  Concentration  ing anti-  trol response 
10_  e .  gen 
Adult (8-10  wk) 
Neonatal (3 days) 
moles hapten 
24  -  -  DNP-Hy 
24  DNP-MTG  10  -5  DNP-Hy  90.0 _+ 30.0 
16  DNP-HTG  10  -5  DNP-Hy  106.8 _+ 14.0 
8  DNP-OVA  10  -5  DNP-Hy  100.0 _+ 20.0 
16  TNP-v-GL  100 ~g/ml  TNP-Hy  106.8 _+ 37.2 
8  DNP-lysine  10  -~  DNP-Hy  100.0 _+ 20.0 
24  -  -  DNP-Hy 
24  DNP-M,.FG  10  -~  DNP-Hy  29.8 +_ 10.0 
22.4  DNP-MTG  10  -s  DNP-Hy  24.0 _+  8.3 
14.4  DNP-M,yG  10  -9  DNP-Hy  16.0 __  4.0 
15.2  DNP-MTG  10  -19  DNP-Hy  72.2 --+.  2.2 
16  DNP-HTG  10  -e  DNP-Hy  19.6 -+ 10.0 
8  DNP-OVA  10  -6  DNP-Hy  20.0 -+ 10.0 
8  TNP-v-GL  100 ~g/ml  TNP-Hy  20.0 -+ 10.0 
16  DNP-lysine  10  -e  DNP-Hy  125.0 -* 25.0 
8  DNPI-S-papain  10  -e  DNP-Hy  70.0 -+ 10.0 
* 4 x 106 donor spleen cells were transferred  to each recipient mouse. 
$ Fragments  were  cultured  for 24 h  in  the presence  or absence of hapten  or hapten-carrier 
conjugates, washed, and stimulated  with either DNP-Hy at 10  -e M DNP or TNP. Clones were 
detected by radioimmunoassay of  culture fluids with 125I-labeled antimouse Fab, IgM, or IgG1. 
vast majority of adult  splenic  B  cells  remain  unaffected by antigen  at  these 
concentrations and concentrations which are four orders of magnitude greater. 
These studies were facilitated by a  modification of the in vitro splenic focus 
technique in which fragment cultures are derived from the spleens of irradiated, 
carrier-primed,  syngeneic adult recipients of neonatal  or adult  B  cells.  These 
recipient  fragment  cultures  permit  the  antigenic  stimulation  of almost  all 
resident transferred  hapten-specific precursor cells by providing all  ancillary 
mechanisms of stimulation  (32).  Furthermore,  hapten-specific B-cell tolerance 
can be studied without the complications ofT-cell tolerance by using one hapten 
carrier for tolerance induction followed by challenge with the same hapten on a 
second carrier to which the recipient has been primed. In addition, the stimula- 
tion of each  B  cell  in  culture  can  be  assessed  in the  absence  of ambiguities 
introduced by cell population effects or the influence of cell localization patterns. 
Finally,  donor cells  are  transferred  in  limited dilutions  which minimizes the 
interaction  between  donor  cells  in  the  recipient  fragments.  Thus,  tolerance 
induction or immune induction of neonatal and adult B cells can be compared at 
the level of individual B cells. In addition, this technique is currently the only 
available method that permits measurable stimulation of neonatal B cells under 
defined conditions and allows the characterization of the isotype and clonotype 
(individual antigenic specificity) of the antibody product of each stimulated B 
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The results demonstrate that, at birth, more than 90% of DNP-specific splenic 
B cells are readily tolerized. Thereafter, the proportion of cells not susceptible to 
tolerance induction  (adult-like  B  cells) constantly increases and attains  adult 
levels by the 7th day after birth. Since the parameters of stimulation of BALB/c 
neonatal splenic B cells have been previously characterized  (29) and the clono- 
types of the  majority of neonatal  BALB/c cells responsive to  DNP and  TNP 
identified  (30-32),  it  is  now possible to  compare  precisely the  parameters  of 
tolerance induction and stimulation of these B cells. The findings show that the 
range  of antigen  concentrations  capable of inducing tolerance  (10  -5 M-10  -9 M 
haptenic  determinant)  closely reflects the concentrations  that  are optimal for 
the stimulation of these cells. The striking similarities between the two mecha- 
nisms  is even more  apparent  when the  exquisite  specificity of tolerance  and 
immune induction of these cells is compared. Previous studies from this labora- 
tory (31,  32) have demonstrated that even though the antibodies, and presum- 
ably the cell receptors, of the three predominant neonatal anti-TNP clonotypes 
can  bind  DNP,  nevertheless,  DNP-Hy  is  unable  to  stimulate  cells  of these 
clonotypes.  The  interpretation  of these  findings  was  consistent  with  earlier 
postulates (28, 32) that the binding of antigen to cell receptors is necessary but 
not sufficient for stimulation.  Furthermore, the specificity of antigenic stimula- 
tion of B cells appeared to be dependent on the intrinsic affinity of the receptor- 
antigen interaction  (28, 32). Since the induction of tolerance in neonatal cells is 
equally specific and thus  also consistent with these interpretations,  these re- 
sults strongly suggest that neonatal tolerance may also be viewed as a  highly 
specific and receptor affinity-dependent event. Therefore, the ability of a cell to 
respond to either an immunogenic or tolerogenic signal would depend solely on 
the maturational  stage of the  B  cell and the presence  or absence of antigen- 
specific T cells. If tolerance induction is a  significant physiological mechanism 
designed to eliminate  B-cell specificities reactive to self-determinants,  then it 
appears  reasonable  to  expect that  the  induction  of such  a  mechanism  would 
require  only  low  antigen  concentrations,  and  that  the  specificity would  be 
exquisite. In contrast to these findings, most previous demonstrations of induced 
hyporeactivity of adult B cells required relatively high antigen concentrations 
(4,  5,  43),  and  tolerance  appeared  to  be  less  specific  than  stimulation.  For 
example,  the adult response to TNP-Hy is reduced by DNP-induced tolerance 
(16),  and H~G tolerance,  which eliminates most H~G binding  B  cells  (2-4%), 
may eliminate many more B cells than comprise the H~G-specific precursor pool 
(22). 
The ability to tolerize neonatal  B  cells by a  wide range  of effective carrier 
moieties is also consistent with the predictions for a  physiologically relevant 
tolerance system. If the establishment of tolerance towards a vast array of self- 
constituents  is  to  be effective,  then  a  tolerance  mechanism  which  would be 
limited to the narrow range of antigenic moieties thus far found to be effective in 
inducing adult B-cell unresponsiveness, such as immunoglobulins or amino acid 
copolymers, would seem too restricted.  It would appear from the studies pre- 
sented here that tolerance of neonatal  B  cells can be induced with hapten  on 
almost any carrier,  provided that the  antigen  is multivalent for the haptenic 
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ently requires  cross-linkage  of receptors,  as  well  as  a  receptor affinity for 
antigen that  exceeds a  minimal threshold,  but no  special requisites  for the 
nature of the carrier moiety. 
Tolerogenic  vs.  Immunogenic  Signals.  It  is  of considerable interest that 
hapten-carrier conjugates stimulated, rather than tolerized, developing B cells 
if the fragment cultures were derived from recipients primed to that carrier. 
Thus, antigen-specific T cells apparently play a pivotal role in the stimulation of 
neonatal B cells. This finding is reminiscent of the two-signal model of B-cell 
stimulation  espoused by  Bretcher and  Cohn  (44) which postulates  that  the 
interaction of antigen with cell receptors is tolerogenic unless a second signal is 
delivered optimally by an antigen-specific T  cell. However, the results of the 
present study are contrary to the predictions of this theory in two major aspects. 
Firstly, tolerance induction appears to pertain only to developing B-cell popula- 
tions. This is reassuring since if this theory were applicable to the adult B cell, 
the frequency of the two-party interaction of the antigen and B cell would far 
exceed the frequency of  the three-party interaction involving the antigen, B cell, 
and specific T cell required for stimulation. Thus antigen contact with B cells, 
particularly before  antigen  priming  of T  cells,  would presumably result  in 
tolerance of all specific B cells. However, a "one signal" tolerance mechanism, 
allowing the elimination of self-reactivities in developing B  cells, could be a 
highly efficient physiological process. 
The  evidence presented  in  this  study also  confirms previous  reports  that 
demonstrated that soluble antigens may bind to mature B cells and even inhibit 
stimulation,  but,  if the  antigen  is  removed before  stimulation,  the  B  cells 
remain unaffected (45,  46).  Therefore, it appears that the "one signal" mode 
(antigen binding to B cells) is irrelevant to mature B cells but tolerogenic to 
developing B  cells (Table IV). However, for both cell types, interactions with 
antigen in conjunction with carrier-specific T cells is stimulatory. These results 
suggest that developing B cells may be prevented from being tolerized in the 
presence of carrier-specific T cells, and thus the recruitment of new (developing) 
B cells during an ongoing immune response would be permitted. It should be 
noted that a role for specific T cells in the induction of mature B-cell tolerance is 
currently a  highly controversial area  (4,  7,  12,  21).  However, since tolerance 
induction of mature  B  cells is  not observed in the splenic fragment culture 
system, the controversy is irrelevant to our findings. It would appear, however, 
TABLE  IV 
Two and Three Party Interactions of Neonatal and Adult B Cells 
Neonatal  Adult  Signal  (immature) B cell  (mature) B cell 
Univalent antigens  Irrelevant  Irrelevant 
Multivalent antigens*  Tolerogenic  Irrelevant 
Multivalent antigens plus  Stimulatory  Stimulatory 
carrier-primed environ- 
ment 
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that tolerance induction of neonatal B  cells  does not require the presence of 
antigen-specific  T cells. 
The findings of this study differ  from the classical  two-signal model in a 
second important aspect: the demonstration that multivalent presentation  of 
haptenic determinants  maximizes  tolerance induction  in developing B  cells. 
Even at 10  -6 M  DNP, neither DNP-lysine nor monovalent DNPi-S-papain is  an 
efficient  tolerogen. Thus, the "first  signal" apparently requires the interlinkage 
of  receptors (multivalent binding) rather than the simple occupation of  receptor 
sites.  This result  is contrary to the previous studies of adult spleen and bone 
marrow B cells  which report that oligovalent antigens or  protein monomers are 
effective  tolerogens (2, 6, 12).  Finally, since  the neonate presumably does not 
have specific  T cells  or antibody with which to polymerize antigens, neonatal 
tolerance may pertain to antigens, such as those on cell  surfaces,  in  which each 
determinant is presented multivalently,  and not to some monomeric  protein 
antigens. 
Tolerance Induction and B-Cell Subpopulations.  The neonatal spleen cells 
analyzed in this study are presumably a  generative population,  doubling in 
number approximately every 24 h, and should thus contain a higher percentage 
of developing cells than the adult spleen. The disparity in the tolerizability of 
cells from 1-3-day neonates vs.  7-day neonates or adult mice confirms this 
presumption and strongly suggests that the vast majority of splenic B cells are 
mature, as determined by their resistance to tolerance induction, by the 7th day 
after birth. This would imply that by 1-wk postparturition, the generative cell 
pool  may reside primarily in the bone marrow. This  is  consistent with the 
finding that a sizeable percentage of the bone marrow cells are tolerizable well 
into the 2nd wk after birth and maintain at least 20% of the cell population 
susceptible to tolerance even in adulthood. (E. S. Metcalf and N. R. Klinman, 
unpublished observations, 27). 
Previous studies have established that the specific  antibody produced after 
stimulation of fetal and perinatal B cells is primarily of the IgM isotype (31, 32, 
47). Although in 3-day spleens both the IgM and IgG1 responses are markedly 
reduced by tolerance induction, the precursors that produce only IgM are by far 
the most susceptible cells. This result provides additional evidence that the least 
mature precursor cells are the most easily tolerized. Unfortunately, it is not yet 
possible  to  correlate  tolerance  susceptibility  with  other  "differentiation 
markers." Recent reports have demonstrated that 10-20% of adult spleen cells 
are Ia negative within the limits of  the experimental design, and this population 
represents the  majority of B  cells  whose clonal  progeny produce only IgM 
antibodies  (48, 49). However, since IgM-producing clones are apparently not 
affected by tolerance induction of adult spleen cells,  it is  unlikely that the 
absence of Ia determinants on B cells correlates with the capacity to be tolerized. 
A similar argument would presumably apply to the 20% of adult splenic B cells 
which are surface IgM positive but lack the "IgD" analogue (50). Furthermore, 
the  resistance to  tolerance susceptibility does not correlate at  all  with  the 
published kinetics of the neonatal acquisition of"IgD" which is present on only a 
small minority of splenic B cells even at day 7 after birth (51). 
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B cells have several properties which distinguish them from adult primary B 
cells and indicate that they may constitute a definable subpopulation (32). It is 
conceivable that the ability to be tolerized in vitro may eventually serve as the 
ultimate marker for developing B cells and B-cell maturation. This criterion has 
already established that the majority of B cells in the adult murine spleen, even 
those that  are  apparently Ia or "IgD" negative, are  mature,  whereas some 
neonatal B cells capable of IgG1 production may be immature. Perhaps the most 
important question in this regard is whether the bone marrow serves as an 
important generative source of cells throughout life. The findings of Nossal and 
Pike (27) and preliminary results from our laboratory indicate that bone marrow 
does contain cells, primarily precursors to clones producing only IgM antibodies, 
which are susceptible to tolerance induction. A detailed analysis of such cells 
and their antibody clonotypes may greatly increase our understanding of the 
ongoing generation of specific B cells. 
Tolerance  Induction  and  the  Acquisition  of the  B-Cell  Specificity  Reper- 
toire.  Recent  evidence,  derived  principally  from  the  analysis  of neonatal 
splenic B cells, has argued that the acquisition of  the B-cell specificity repertoire 
is a highly ordered, genetically determined process (31, 32, 52-54). "Germ line" 
theories  of diversity generation,  even  those  postulating  the  predetermined 
somatic variation of"germ line" information (32, 52, 53), rely heavily on evolu- 
tionary selective forces to  provide a  highly selected repertoire.  Within  this 
context, the existence of a tolerance mechanism, which eliminates potentially 
harmful specificities during development, would seem anachronistic. However, 
given the apparent genetic polymorphic expression of various antigenic determi- 
nants, particularly cell-associated antigenic determinants, all theories of diver- 
sity generation would require a  mechanism whereby the F1 generation recog- 
nized parental determinants as self. In this regard, a  highly specific,  widely 
applicable,  and  extremely sensitive tolerance mechanism which pertains to 
developing B cells would seem ideal. 
Thus it has been established in this report that only during their development 
can B cells be tolerized in vitro in a highly specific manner, by low concentra- 
tions of a  wide array of multivalent antigens. This in vitro tolerance system 
should provide a  model with which the molecular mechanism(s) of tolerance 
induction to self-antigens may be more thoroughly investigated. 
Summary 
The susceptibility of neonatal and adult B lymphocytes to tolerance induction 
was analyzed by a  modification of the in vitro splenic focus technique. This 
technique permits stimulation of individual hapten-specific clonal precursor 
cells from both neonatal and adult donors. Neonatal or adult BALB/c spleen 
cells were adoptively transferred into irradiated,  syngeneic, adult recipients 
which had been carrier-primed to hemocyanin (Hy), thus maximizing stimula- 
tion to the hapten 2,4-dinitrophenyl coupled to Hy (DNP-Hy). Cultures were 
initially treated with DNP on several heterologous (non-Hy) carriers and subse- 
quently stimulated with DNP-Hy. Whereas the responsiveness of adult B cells 
was not diminished by pretreatment with any DNP conjugate, the majority of 
the neonatal B-cell  response was abolished by in vitro culture with all of the 1338  TOLERANCE  INDUCTION  OF  NEONATAL  MURINE  B  CELLS 
DNP-protein conjugates. During the 1st wk of life, the ability to tolerize neo- 
natal splenic B cells progressively decreased. Thus, tolerance in this system is: 
(a) restricted to B cells early in development; (5) established by both tolerogens 
and immunogens; (c)  achieved at low (10  -9 M determinant) antigen concentra- 
tions; and (d) highly specific, discriminating between DNP- and TNP-specific B 
cells. We conclude that: (a) B lymphoeytes, during their development, mature 
through a stage in which they are extremely susceptible to tolerogenesis; (5) the 
specific interaction of B-cell antigen receptors with multivalent antigens, while 
irrelevant to mature B cells, is tolerogenic to neonatal (immature) B cells unless 
antigen is concomitantly recognized by primed T cells; and (c) differences in the 
susceptibility of immature and mature B  lymphocytes to tolerance induction 
suggest  intrinsic  differences between  neonatal  and  adult  B  cells  and  may 
provide  a  physiologically relevant  model  for the  study of tolerance to  self- 
antigens. 
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